The dual function of hepatic SOCS3 in insulin resistance in vivo

Takehiro Torisu, Naoichi Sato, Daigo Yoshiga, Takashi Kobayashi, Tomoko Yoshioka, Hiroyuki Mori, Mitsuo Iida, Akihiko Yoshimura

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Inflammation associates with insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. The suppressor of cytokine signaling 3 (SOCS3), which is induced by pro-inflammatory cytokines, such as TNFα and IL-6, has been implicated in inflammation-mediated insulin resistance in the liver and adipocytes. However, no genetic evidence has been provided for the involvement of SOCS3 on insulin resistance. Here, we generated hepatocyte-specific SOCS3-deficient (L-SOCS3 cKO) mice and examined insulin sensitivity. Being consistent with a previous idea, the loss of SOCS3 in the liver apparently improved insulin sensitivity. However, unexpectedly, L-SOCS3 cKO mice exhibited obesity and systemic insulin resistance with age. Insulin signaling was rather suppressed in muscles, suggesting that deletion of the SOCS3 gene in the liver modulates insulin sensitivity in other organs. Anti-inflammatory reagent, sodium salicylate, partial improved insulin resistance of aged L-SOCS3 cKO mice, suggesting that enhanced inflammatory status is associated with the phenotype of these mice. STAT3 was hyperactivated and acute-phase proteins were elevated in L-SOCS3 cKO mice liver, which were reduced by sodium salicylate treatment. We conclude that hepatic SOCS3 is a mediator of insulin resistance in the liver; however, lack of SOCS3 in the liver promotes systemic insulin resistance by mimicking chronic inflammation.

Original languageEnglish
Pages (from-to)143-154
Number of pages12
JournalGenes to Cells
Volume12
Issue number2
DOIs
Publication statusPublished - 2007 Feb
Externally publishedYes

Fingerprint

Insulin Resistance
Cytokines
Liver
Sodium Salicylate
Inflammation
Acute-Phase Proteins
Adipocytes
Hepatocytes
Interleukin-6
Homeostasis
Anti-Inflammatory Agents
Obesity
Insulin
Phenotype
Food
Muscles

ASJC Scopus subject areas

  • Genetics
  • Cell Biology

Cite this

Torisu, T., Sato, N., Yoshiga, D., Kobayashi, T., Yoshioka, T., Mori, H., ... Yoshimura, A. (2007). The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes to Cells, 12(2), 143-154. https://doi.org/10.1111/j.1365-2443.2007.01044.x

The dual function of hepatic SOCS3 in insulin resistance in vivo. / Torisu, Takehiro; Sato, Naoichi; Yoshiga, Daigo; Kobayashi, Takashi; Yoshioka, Tomoko; Mori, Hiroyuki; Iida, Mitsuo; Yoshimura, Akihiko.

In: Genes to Cells, Vol. 12, No. 2, 02.2007, p. 143-154.

Research output: Contribution to journalArticle

Torisu, T, Sato, N, Yoshiga, D, Kobayashi, T, Yoshioka, T, Mori, H, Iida, M & Yoshimura, A 2007, 'The dual function of hepatic SOCS3 in insulin resistance in vivo', Genes to Cells, vol. 12, no. 2, pp. 143-154. https://doi.org/10.1111/j.1365-2443.2007.01044.x
Torisu T, Sato N, Yoshiga D, Kobayashi T, Yoshioka T, Mori H et al. The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes to Cells. 2007 Feb;12(2):143-154. https://doi.org/10.1111/j.1365-2443.2007.01044.x
Torisu, Takehiro ; Sato, Naoichi ; Yoshiga, Daigo ; Kobayashi, Takashi ; Yoshioka, Tomoko ; Mori, Hiroyuki ; Iida, Mitsuo ; Yoshimura, Akihiko. / The dual function of hepatic SOCS3 in insulin resistance in vivo. In: Genes to Cells. 2007 ; Vol. 12, No. 2. pp. 143-154.
@article{c632ee4436e8425c9677a7004fe643a2,
title = "The dual function of hepatic SOCS3 in insulin resistance in vivo",
abstract = "Inflammation associates with insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. The suppressor of cytokine signaling 3 (SOCS3), which is induced by pro-inflammatory cytokines, such as TNFα and IL-6, has been implicated in inflammation-mediated insulin resistance in the liver and adipocytes. However, no genetic evidence has been provided for the involvement of SOCS3 on insulin resistance. Here, we generated hepatocyte-specific SOCS3-deficient (L-SOCS3 cKO) mice and examined insulin sensitivity. Being consistent with a previous idea, the loss of SOCS3 in the liver apparently improved insulin sensitivity. However, unexpectedly, L-SOCS3 cKO mice exhibited obesity and systemic insulin resistance with age. Insulin signaling was rather suppressed in muscles, suggesting that deletion of the SOCS3 gene in the liver modulates insulin sensitivity in other organs. Anti-inflammatory reagent, sodium salicylate, partial improved insulin resistance of aged L-SOCS3 cKO mice, suggesting that enhanced inflammatory status is associated with the phenotype of these mice. STAT3 was hyperactivated and acute-phase proteins were elevated in L-SOCS3 cKO mice liver, which were reduced by sodium salicylate treatment. We conclude that hepatic SOCS3 is a mediator of insulin resistance in the liver; however, lack of SOCS3 in the liver promotes systemic insulin resistance by mimicking chronic inflammation.",
author = "Takehiro Torisu and Naoichi Sato and Daigo Yoshiga and Takashi Kobayashi and Tomoko Yoshioka and Hiroyuki Mori and Mitsuo Iida and Akihiko Yoshimura",
year = "2007",
month = "2",
doi = "10.1111/j.1365-2443.2007.01044.x",
language = "English",
volume = "12",
pages = "143--154",
journal = "Genes to Cells",
issn = "1356-9597",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - The dual function of hepatic SOCS3 in insulin resistance in vivo

AU - Torisu, Takehiro

AU - Sato, Naoichi

AU - Yoshiga, Daigo

AU - Kobayashi, Takashi

AU - Yoshioka, Tomoko

AU - Mori, Hiroyuki

AU - Iida, Mitsuo

AU - Yoshimura, Akihiko

PY - 2007/2

Y1 - 2007/2

N2 - Inflammation associates with insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. The suppressor of cytokine signaling 3 (SOCS3), which is induced by pro-inflammatory cytokines, such as TNFα and IL-6, has been implicated in inflammation-mediated insulin resistance in the liver and adipocytes. However, no genetic evidence has been provided for the involvement of SOCS3 on insulin resistance. Here, we generated hepatocyte-specific SOCS3-deficient (L-SOCS3 cKO) mice and examined insulin sensitivity. Being consistent with a previous idea, the loss of SOCS3 in the liver apparently improved insulin sensitivity. However, unexpectedly, L-SOCS3 cKO mice exhibited obesity and systemic insulin resistance with age. Insulin signaling was rather suppressed in muscles, suggesting that deletion of the SOCS3 gene in the liver modulates insulin sensitivity in other organs. Anti-inflammatory reagent, sodium salicylate, partial improved insulin resistance of aged L-SOCS3 cKO mice, suggesting that enhanced inflammatory status is associated with the phenotype of these mice. STAT3 was hyperactivated and acute-phase proteins were elevated in L-SOCS3 cKO mice liver, which were reduced by sodium salicylate treatment. We conclude that hepatic SOCS3 is a mediator of insulin resistance in the liver; however, lack of SOCS3 in the liver promotes systemic insulin resistance by mimicking chronic inflammation.

AB - Inflammation associates with insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. The suppressor of cytokine signaling 3 (SOCS3), which is induced by pro-inflammatory cytokines, such as TNFα and IL-6, has been implicated in inflammation-mediated insulin resistance in the liver and adipocytes. However, no genetic evidence has been provided for the involvement of SOCS3 on insulin resistance. Here, we generated hepatocyte-specific SOCS3-deficient (L-SOCS3 cKO) mice and examined insulin sensitivity. Being consistent with a previous idea, the loss of SOCS3 in the liver apparently improved insulin sensitivity. However, unexpectedly, L-SOCS3 cKO mice exhibited obesity and systemic insulin resistance with age. Insulin signaling was rather suppressed in muscles, suggesting that deletion of the SOCS3 gene in the liver modulates insulin sensitivity in other organs. Anti-inflammatory reagent, sodium salicylate, partial improved insulin resistance of aged L-SOCS3 cKO mice, suggesting that enhanced inflammatory status is associated with the phenotype of these mice. STAT3 was hyperactivated and acute-phase proteins were elevated in L-SOCS3 cKO mice liver, which were reduced by sodium salicylate treatment. We conclude that hepatic SOCS3 is a mediator of insulin resistance in the liver; however, lack of SOCS3 in the liver promotes systemic insulin resistance by mimicking chronic inflammation.

UR - http://www.scopus.com/inward/record.url?scp=33846512401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846512401&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2443.2007.01044.x

DO - 10.1111/j.1365-2443.2007.01044.x

M3 - Article

VL - 12

SP - 143

EP - 154

JO - Genes to Cells

JF - Genes to Cells

SN - 1356-9597

IS - 2

ER -